Definitive Contract HHSD200201588233C
Award Date
9/28/15
Potential Completion Date
9/27/17
Potential Value
$987K
Federal Agency
CDC Pittsburgh
Awardee
Microbplex Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The U.S. Centers for Disease Control and Prevention (CDC) awarded a $242,905.00 Small Business Innovation Research (SBIR) Phase I contract to Mifi, LLC, a woman-owned small business, for SBIR Topic 36. The firm fixed price purchase order was awarded on September 16, 2024 and has an ultimate completion date of March 30, 2025. The contract is set aside for total small business and supports the CDC's research and development initiatives in Stillwater, Oklahoma.</p>
This is a SBIR Phase I contract award to Cytoimage Inc., a woman-owned small business, by the Centers for Disease Control and Prevention (CDC) of the Department of Health and Human Services (HHS). The award is for $149,531.00 and is a firm fixed price contract. The contract does not have a set-aside designation. The period of performance is from September 12, 2017 to March 11, 2018, with work to be performed in Atlanta, Georgia. The SBIR (Small Business Innovation Research) program is a...
This is a federal SBIR Phase II contract award to Carrera Bioscience Inc., a for-profit, economically disadvantaged woman-owned small business, by the Centers for Disease Control and Prevention (CDC). The contract, valued at $604,500.00, is a Cost Plus Fixed Fee definitive contract with a completion date of September 25, 2018. The contract does not have a set-aside designation. Based on the SBIR Phase II designation, this award is likely part of the CDC's small business innovation research...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) Pittsburgh office to Micron Biomedical Inc., a for-profit small business. The $150,000 contract is for SBIR Phase 1 research and development of "other functions" under Topic 31, with a period of performance ending on March 10, 2017. The work is being performed in Atlanta, Georgia. Micron Biomedical Inc. is a manufacturer of...
<p>The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Small Business Innovation Research (SBIR) Phase I contract to Hdox Bioinformatics Inc., a minority-owned, woman-owned small business. The $147,702.00 firm-fixed-price purchase order contract has a completion date of September 29, 2019. The work is being performed in Atlanta, Georgia. The contract does not have a set-aside designation.</p>
This is a $717,999.84 cost plus fixed fee contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Qoolabs Inc., a self-certified small disadvantaged, woman-owned business. The contract was awarded under the Small Business Innovation Research (SBIR) Phase II program, which provides funding to small businesses for the research and development of innovative technologies. Under this contract, Qoolabs Inc. will conduct research and development...
<p>This federal contract award is for a Small Business Innovation Research (SBIR) Phase I project awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Ifyber LLC, a for-profit limited liability company. The contract has a firm fixed price of $149,982.96 and was awarded on August 27, 2018, with a completion date of August 12, 2019. The place of performance is Ithaca, NY. This SBIR Phase I award does not have a set-aside designation.</p>
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $216,444 Small Business Innovation Research (SBIR) Phase I contract to Crosslife Technologies Inc., a self-certified small disadvantaged business, to conduct research and development on diagnostics to enable the detection and elimination of malaria and neglected tropical diseases. The contract was awarded under the NIH/CDC SBIR Contract Solicitation PHS...
This federal contract award is for SBIR Phase II research and development work by Qoolabs Inc., a self-certified small disadvantaged business. The $749,999 cost-plus-fixed-fee contract was awarded on September 5, 2017 by the Department of Health and Human Services Centers for Disease Control and Prevention. The work is being performed in Atlanta, Georgia and involves the development of medical technologies related to infectious diseases, immunology, and cancer detection. This includes research...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $242,847.00 firm fixed price purchase order contract to Mendon Group Solutions, a minority-owned and self-certified small disadvantaged business, for Phase 1 SBIR work. The contract is for performance in Honeoye Falls, NY and has a completion date of May 29, 2023. SBIR refers to the Small Business Innovation Research program, which provides opportunities for small businesses to participate in federal...